导弹(火箭)固体发动机动力与控制产品
Search documents
国科军工:目前公司与商业航天企业合作推进运载火箭项目尚处于研发阶段
Zhi Tong Cai Jing· 2026-01-12 13:28
国科军工(688543.SH)发布股价异动公告称,公司主营业务为导弹(火箭)固体发动机动力与控制产品及弹 药装备的研发、生产与销售,目前公司与商业航天企业合作推进运载火箭项目尚处于研发阶段,尚未产 生定型产品,在主营业务收入中占比极低(不足1%),且二级市场交易和估值受多方面因素影响,股价短 期内连续上涨存在市场情绪过热、非理性炒作风险,特别提醒广大投资者,注意投资风险,理性决策, 审慎投资。 ...
国科军工:与商业航天企业合作推进运载火箭项目尚处于研发阶段 尚未产生定型产品
Mei Ri Jing Ji Xin Wen· 2026-01-12 10:56
每经AI快讯,1月12日,国科军工(688543.SH)公告称,公司股票连续三个交易日内价格涨幅偏离值累计 超过30%,属于股票交易异常波动情形。经核实,公司不存在应披露而未披露的重大事项。公司主营业 务为导弹(火箭)固体发动机动力与控制产品及弹药装备的研发、生产与销售,与商业航天企业合作推进 运载火箭项目尚处于研发阶段,尚未产生定型产品,在主营业务收入中占比极低。二级市场交易和估值 受多方面因素影响,股价短期内连续上涨存在市场情绪过热、非理性炒作风险。 ...
国科军工全资子公司签订4.66亿元军贸产品发动机装药合同
Zheng Quan Shi Bao Wang· 2025-10-29 10:20
Core Viewpoint - Guokexingong (国科军工) has signed a significant annual order contract worth 466 million yuan for military trade products, which is expected to positively impact its performance in the coming year [1][2]. Group 1: Contract and Financial Performance - The company’s wholly-owned subsidiary, Jiangxi Aerospace Jingwei Chemical Co., has entered into a confidential contract with a military unit, with a contract value of 466 million yuan, effective until December 25, 2026 [1]. - In addition to the recent contract, the company has secured multiple important contracts this year, including a total of 739 million yuan for ammunition products for 2025 [2]. - For the first three quarters of the year, the company reported a revenue of 775 million yuan, a year-on-year increase of 1.49%, while net profit was 143 million yuan, reflecting a slight decline of 4.21% [2]. Group 2: Production Capacity and Development Strategy - The company is enhancing its production capacity through specialized production lines, with ongoing projects aimed at increasing the capacity of its ammunition production by over 20% [2]. - Future development will focus on expanding capacity to meet new production tasks, entering the aerospace power sector, and advancing the integration of solid engine research and production [3]. - The company aims to achieve a compound annual growth rate of no less than 15% in revenue and net profit during the 14th Five-Year Plan period [3].